Literature DB >> 3594383

Effects of the mass screening of neuroblastoma in Sapporo City.

M Nishi, H Miyake, T Takeda, M Shimada, N Takasugi, Y Sato, J Hanai.   

Abstract

One hundred sixty-seven cases of neuroblastoma in the Registry of Childhood Malignancies in Hokkaido Prefecture from 1969 to 1984 were studied, using the age at diagnosis, the clinical stage at diagnosis, and the survival rate to assess the influence of the mass screening of neuroblastoma performed in Sapporo City since 1981. In Sapporo City, the capital of Hokkaido Prefecture, the condition of the three parameters improved significantly after the institution of mass screening (e.g., the 48-month survival rate improved--from 21.3% to 87.5%). In Hokkaido Prefecture (Sapporo City excluded), however, where the mass screening had not yet been performed, no significant change was observed in any of the three parameters (48-month survival rate changed only from 21.1% to 28.1%). Consequently, the improvement in Sapporo City was thought to be attributable to the effects of the mass screening.

Entities:  

Mesh:

Year:  1987        PMID: 3594383     DOI: 10.1002/1097-0142(19870801)60:3<433::aid-cncr2820600326>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Screening for neuroblastoma in the north of England.

Authors:  L Parker; A W Craft; G Dale; S Bell; M Cole; A C McGill; J A Seviour; J Smith
Journal:  BMJ       Date:  1992-11-21

2.  Screening for neuroblastoma.

Authors:  G J Draper
Journal:  BMJ       Date:  1988-07-16

3.  Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma.

Authors:  M Nishi; H Miyake; T Takeda; K Yamashiro; N Takasugi; J Hanai; T Kawai
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

Review 4.  Clinical presentations and imaging findings of neuroblastoma beyond abdominal mass and a review of imaging algorithm.

Authors:  C M Chu; D D Rasalkar; Y J Hu; F W T Cheng; C K Li; W C W Chu
Journal:  Br J Radiol       Date:  2011-01       Impact factor: 3.039

5.  Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.

Authors:  Tadaharu Okazaki; Sumio Kohno; Jun-ichi Mimaya; Shiro Hasegawa; Naoto Urushihara; Atsushi Yoshida; Shinya Kawano; Junichi Kusafuka; Yasuo Horikoshi; Yoshifumi Takashima; Katsuhiko Aoki; Minoru Hamazaki
Journal:  Pediatr Surg Int       Date:  2003-12-19       Impact factor: 1.827

6.  [Neuroblastoma in children].

Authors:  M Hörmann
Journal:  Radiologe       Date:  2008-10       Impact factor: 0.635

7.  Poor prognosis neuroblastoma: is screening the answer?

Authors:  A W Craft; L Parker
Journal:  Br J Cancer Suppl       Date:  1992-08

8.  Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma.

Authors:  Denis Andrew Cozzi; Ermelinda Mele; Silvia Ceccanti; Fabio Natale; Anna Clerico; Amalia Schiavetti; Carlo Dominici
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

9.  Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases.

Authors:  M Nishi; H Miyake; T Takeda; N Takasugi; Y Sato; J Hanai
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

10.  Involvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cells.

Authors:  Qi Zhang; Yan Ma; Yue-Fang Cheng; Wen-Jie Li; Zhenzhong Zhang; Shao-Yu Chen
Journal:  Cancer Lett       Date:  2011-09-17       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.